Powder Coating

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Solar energy solutions this is one of the first units to apply clean energy with a roof-mounted design with a capacity of 44 million kWh.

This factory model applies solar energy to improve operational efficiency, environmentally friendly production and increase brand image. This is considered the largest solar power plant in Vietnam.

This factory model applies solar energy to improve operational efficiency, environmentally friendly production and increase brand image. This is considered the largest solar power plant in Vietnam.

    TELL US WHAT'S YOUR STORY?

    For further information on our services, please complete the form below and one of our team members will contact you

    Product Features

    • Hight Quality
      Lorem ipsum is placeholder text commonly used in the graphic, print, and publishing industries for previewing layouts and visual mockups.
    • Awesome Design
      Lorem ipsum is placeholder text commonly used in the graphic, print, and publishing industries for previewing layouts and visual mockups.
    • Latest technology
      Lorem ipsum is placeholder text commonly used in the graphic, print, and publishing industries for previewing layouts and visual mockups.
    • User Friendly
      Lorem ipsum is placeholder text commonly used in the graphic, print, and publishing industries for previewing layouts and visual mockups.

    Best Product For You.
    Check the demo Video

    Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

    Product information

    • Solar water heaters
      The energy in sunlight is in the form of electromagnetic radiation from the infrared (long) to the ultraviolet (short) wavelengths.
    • Solar collectors
      The energy in sunlight is in the form of electromagnetic radiation from the infrared (long) to the ultraviolet (short) wavelengths.
    • Water tanks
      The energy in sunlight is in the form of electromagnetic radiation from the infrared (long) to the ultraviolet (short) wavelengths.
    • Solar powe
      The energy in sunlight is in the form of electromagnetic radiation from the infrared (long) to the ultraviolet (short) wavelengths.

    Along with their colleagues, Dr. Jonathan Loree, a medical oncologist and assistant professor at the University of British Columbia in Vancouver in Canada and Dr. Kanwal Raghav, an associate professor in the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston analyzed 230 oncology clinical trials. These trials took place between 2008–2018 and resulted in the Food and Drug Administration (FDA) approving cancer drugs.

    They found that only 145 (63%) of the 230 trials, included any information about the participant’s race. More specifically, only 18 trials (7.8%) gave a breakdown of the participants by the “four major races in the United States (white, Asian, Black, and Hispanic)” as the authors put it.
    On average, 76.3% of the participants were white, 18.3% Black, 3.1% Asian, and 6.1% Hispanic. In the period that the authors looked at, these percentages changed only marginally.

    Along with their colleagues, Dr. Jonathan Loree, a medical oncologist and assistant professor at the University of British Columbia in Vancouver in Canada and Dr. Kanwal Raghav, an associate professor in the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston analyzed 230 oncology clinical trials. These trials took place between 2008–2018 and resulted in the Food and Drug Administration (FDA) approving cancer drugs.

    They found that only 145 (63%) of the 230 trials, included any information about the participant’s race. More specifically, only 18 trials (7.8%) gave a breakdown of the participants by the “four major races in the United States (white, Asian, Black, and Hispanic)” as the authors put it.
    On average, 76.3% of the participants were white, 18.3% Black, 3.1% Asian, and 6.1% Hispanic. In the period that the authors looked at, these percentages changed only marginally.

    Along with their colleagues, Dr. Jonathan Loree, a medical oncologist and assistant professor at the University of British Columbia in Vancouver in Canada and Dr. Kanwal Raghav, an associate professor in the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston analyzed 230 oncology clinical trials. These trials took place between 2008–2018 and resulted in the Food and Drug Administration (FDA) approving cancer drugs.